We are live on
!
Find out more
LD
Lipe & Dalton Portfolio holdings
AUM
$215M
1-Year Est. Return
39.53%
This Fund
S&P 500
This Quarter
Est. Return
+8.35%
1 Year Est. Return
+39.53%
3 Year Est. Return
+89.64%
5 Year Est. Return
+111.74%
10 Year Est. Return
+427.59%
AUM
$185M
AUM Growth
+$6.35M
(+3.6%)
Cap. Flow
-$4.39M
Cap. Flow
% of AUM
-2.37%
Top 10 Holdings %
Top 10 Hldgs %
41.23%
Holding
94
New
5
Increased
11
Reduced
47
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$3.93M |
| 2 |
Accenture
ACN
|
+$492K |
| 3 |
Capital One
COF
|
+$275K |
| 4 |
APA Corp
APA
|
+$109K |
| 5 |
Philip Morris
PM
|
+$67.8K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.7M |
| 2 |
Cooper Companies
COO
|
+$1.02M |
| 3 |
Constellation Brands
STZ
|
+$769K |
| 4 |
Apple
AAPL
|
+$397K |
| 5 |
EXAS
Exact Sciences
EXAS
|
+$317K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.95% |
| 2 | Industrials | 19.83% |
| 3 | Financials | 19.25% |
| 4 | Healthcare | 14.29% |
| 5 | Communication Services | 7.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Walt Disney
DIS
$167B
| $184K | 0.1% |
1,480
-200
| -12% | -$20.8K |
|
77
Broadcom
AVGO
$1.85T
| $125K | 0.07% |
454
-100
| -18% | -$21.7K |
|
78
Mondelez International
MDLZ
$79.5B
| $116K | 0.06% |
1,721
| – | – |
|
79
Coca-Cola
KO
$377B
| $113K | 0.06% |
1,600
| – | – |
|
|
80
Bristol-Myers Squibb
BMY
$133B
| $94K | 0.05% |
2,020
-54,979
| -96% | -$2.7M |
|
|
81
Philip Morris
PM
$297B
| $72K | 0.04% |
+395
| New | +$67.8K |
|
82
Advanced Micro Devices
AMD
$776B
| $67K | 0.04% |
+470
| New | +$51.2K |
|
83
Pfizer
PFE
$143B
| $64K | 0.03% |
2,659
| – | – |
|
84
Walmart Inc
WMT
$885B
| $40K | 0.02% |
410
| – | – |
|
85
Alphabet (Google) Class A
GOOGL
$4.36T
| $31K | 0.02% |
178
| – | – |
|
86
Duke Energy
DUK
$97.8B
| $29K | 0.02% |
243
-100
| -29% | -$11.8K |
|
87
IBM
IBM
$211B
| $29K | 0.02% |
100
| – | – |
|
88
Union Pacific
UNP
$174B
| $23K | 0.01% |
100
+78
| +355% | +$17.3K |
|
89
Scotiabank
BNS
$107B
| $7K | ﹤0.01% |
+125
| New | +$6.36K |
|
|
90
Cooper Companies
COO
$14.1B
| – | – |
-12,096
| Closed | -$1.02M |
|
|
DFS
91
DELISTED
Discover Financial Services
DFS
| – | – |
-1,300
| Closed | -$222K |
|
|
EXAS
92
DELISTED
Exact Sciences
EXAS
| – | – |
-7,320
| Closed | -$317K |
|
|
93
Constellation Brands
STZ
$22.2B
| – | – |
-4,190
| Closed | -$769K |
|
Similar funds
VEA
NCM
VFG
SSA
LIWM
IAM
1M
RC
Lipe & Dalton's Q2 2025 Portfolio in Review
As of Q2 2025, Lipe & Dalton held 94 positions worth $185M, up 3.6% from $179M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Lipe & Dalton's Q2 2025 filing shows 5 new, 11 increased, 47 reduced and 4 closed positions. Its largest new stake was Thermo Fisher Scientific: 9,404 shares worth $3.81M. The largest sale was Bristol-Myers Squibb, an estimated $2.7M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Industrials and Financials.
- Lipe & Dalton's largest Q2 2025 buy was Thermo Fisher Scientific: 9,404 shares worth $3.81M.
- Lipe & Dalton added most to Accenture in Q2 2025, an estimated $492K increase.
- Lipe & Dalton's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $2.7M.
- Lipe & Dalton fully exited Cooper Companies in Q2 2025, selling an estimated $1.02M.
- Lipe & Dalton's ten largest holdings make up 41% of its $185M portfolio in Q2 2025.
- Lipe & Dalton opened 5 new positions and closed 4 in Q2 2025.
- Lipe & Dalton's portfolio value rose 3.6% quarter-over-quarter to $185M.
Based on Lipe & Dalton's 13F filing for Q2 2025, filed 1 Aug 2025.